Perrigo Confirms Filing of Generic Version of Astepro Nasal Spray
Perrigo announced that it has filed with the FDA an Abbreviated New Drug Application (ANDA) for Azelastine HCl nasal spray (0.15%), a generic of Astepro Nasal Spray. Perrigo has notified Meda, the manufacturer of Astepro.
Azelastine HCl nasal spray is indicated for the treatment of seasonal and perennial allergic rhinitis in patients ≥12 years old.
For more information, call (866) 634-9120 or visit www.perrigo.com.